Le Lézard
Classified in: Health
Subject: FEA

Mentice receives order of total SEK 5.9 million from Baylis Medical Company


STOCKHOLM, June 30, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on interventional procedures, has entered into an agreement with Baylis Medical Company ("Baylis") to provide simulation solutions.

Based on this order, Mentice will support Baylis' product portfolio for transseptal puncture procedures with Mentice systems to be delivered in the second and third quarter of 2021.

The systems are based on the Mentice' VIST G5 platform and will support Baylis commercialization efforts to launch new medical devices in a safe and effective way by supporting clinical education.

The order will be accounted in the order book for the Medical Device Industry segment during the second quarter of 2021. The total value for the order amounts to SEK 5.9 million.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: [email protected] 
US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22

About Mentice

Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular and peripheral interventions are just some of the clinical areas covered by our solutions. More information on www.mentice.com

This information is information that Mentice AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person, at 11.30 on June 30, 2021.  

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB, phone +46 8 528 00 399

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/mentice-ab/r/mentice-receives-order-of-total-sek-5-9-million-from-baylis-medical-company,c3376974

The following files are available for download:

https://mb.cision.com/Main/18275/3376974/1438734.pdf

Release

SOURCE Mentice AB


These press releases may also interest you

at 20:59
Jacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were offically reported at the April ASCO Plenary Series, which was held online. Prof. Yuankai Shi, chief physician of...

at 20:08
Waverley Pharma Inc. ("Waverley Pharma" or the "Company") , a Canadian pharmaceutical company, is announcing a business update. As mentioned in the previous business update dated August 2, 2023, opportunities Waverley Pharma envisioned of marketing...

at 19:46
Feeding Matters is proud to celebrate the 6th annual PFD Awareness Month, which is recognized around the globe. This designation, initiated by Feeding...

at 18:57
Korea Ginseng Corp. US (KGCUS) aka JungKwanJang held a dedicated international seminar session on "Korean Ginseng: Safety, Efficacy And Neuroprotective Insights'' at the International Conference on the Science of Botanicals (ICSB) hosted by the...

at 18:33
More than 500 life science professionals gathered at Momentum Labs | Alachua for BioFlorida's 19th Annual Celebration of Biotechnology. This lively community event offered attendees the opportunity to connect with industry leaders, learn about new...

at 18:33
MedStar Health unveiled its newly renovated and expanded Curtis National Hand Center (CNHC) at MedStar Union Memorial Hospital April 24th, during a ribbon cutting celebration centered on philanthropy, the historical significance the center has on...



News published on and distributed by: